SETD2 Mutation in an Aggressive Optic Nerve Glioma-Reference-Cited by-同舟云学术

SETD2 Mutation in an Aggressive Optic Nerve Glioma

Published:2020-01-01 Issue:1 Volume:138 Page:102
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Campbell Ashley A.¹²,Gartrell-Corrado Robyn D.³,Mansukhani Mahesh⁴,Zanazzi George⁴,Canoll Peter⁴,Garvin James H.³,Kazim Michael²

Affiliation:

1. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Ophthalmic Plastic and Reconstructive Surgery, Orbital Surgery Division, Department of Ophthalmology, New York Presbyterian Hospital, Columbia University Irving Medical Center, New York

3. Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York

4. Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2753930/jamaophthalmology_campbell_2019_lo_190013.pdf

Reference6 articles.

1. Magnetic resonance imaging evidence of optic nerve glioma progression into and beyond the optic chiasm.;Walrath;Ophthalmic Plast Reconstr Surg,2008

2. Optic pathway gliomas are tumors!;Miller;Ophthalmic Plast Reconstr Surg,2008

3. BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper.;Rodriguez;J Neuropathol Exp Neurol,2012

4. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.;Jones;Cancer Res,2008